Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Director comp.
Consulting agrmnt
Quarterly results
Inv. presentation
Director departure
|
|
Augmedix, Inc. (AUGX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/13/2023 |
8-K
| Quarterly results |
| 08/14/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/07/2023 |
8-K
| Quarterly results|
Docs:
|
"Augmedix Delivers 47% Revenue Growth and Expanded Gross Margins for Second Quarter of 2023 SAN FRANCISCO, August 7, 2023 – Augmedix , a healthcare technology company that delivers industry-leading ambient medical documentation and data solutions to healthcare systems, physician practices, hospitals, and telemedicine practitioners, today reported financial results for the three and six months ended June 30, 2023. “This was another strong quarter for Augmedix, as we continue to solidify our position within the burgeoning ambient medical documentation market,” commented Manny Krakaris, Chief Executive Officer at Augmedix. “We set records for revenue, growing 47% year-over-year, and dollar-based net revenue retention at 148%, demonstrating that health systems and clinicians increasingly value ..." |
|
| 07/17/2023 |
8-K
| Resignation/termination of a director |
| 07/14/2023 |
8-K
| Quarterly results |
| 06/15/2023 |
SC 13D/A
| Redmile Group, LLC reports a 44.7% stake in Augmedix, Inc. |
| 06/12/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 06/09/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 05/19/2023 |
S-3
| Form S-3 - Registration statement under Securities Act of 1933: |
| 05/18/2023 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits Interactive Data |
| 05/15/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/12/2023 |
8-K
| Investor presentation, Quarterly results |
| 05/09/2023 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits Interactive Data |
| 05/04/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 04/28/2023 |
10-K/A
| Annual Report for the period ended December 31, 2022 [amend] |
| 04/21/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 04/20/2023 |
8-K
| Quarterly results |
| 04/17/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 04/14/2023 |
8-K
| Quarterly results |
| 03/31/2023 |
NT 10-K
| Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405: |
| 03/27/2023 |
8-K
| Quarterly results|
Docs:
|
"Augmedix Reports Strong Commercial Traction and Sales Momentum; Reports Fourth Quarter and Full Year 2022 Financial Results SAN FRANCISCO, Calif. –– March 27, 2023 –– Augmedix , a leading provider of ambient medical documentation and data solutions delivered remotely to healthcare systems, physician practices, hospitals, and telemedicine practitioners, today reported financial results for the three and 12 months ended December 31, 2022. “We finished 2022 with our best-ever fourth quarter in terms of bookings, with sales momentum continuing into 2023 with record first-quarter bookings, including our largest-ever clinician cohort signed,” said Manny Krakaris, Chief Executive Officer at Augmedix. “Our expanding portfolio of products has positioned us well for the large market opportunity in f..." |
|
| 03/13/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 03/06/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 02/06/2023 |
8-K
| Quarterly results |
| 01/26/2023 |
SC 13D/A
| DCM VI, L.P. reports a 11.9% stake in Augmedix, Inc. |
| 01/12/2023 |
8-K
| Quarterly results |
| 01/10/2023 |
8-K
| Quarterly results |
| 01/10/2023 |
8-K
| Quarterly results |
| 12/28/2022 |
8-K
| Quarterly results |
| 12/21/2022 |
8-K
| Quarterly results |
| 12/16/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 11/18/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
| 11/14/2022 |
NT 10-Q
| Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB: |
| 11/14/2022 |
8-K
| Quarterly results |
|
|
|